Document Detail

State of the Art Management of Transfusion-Related Acute Lung Injury (TRALI).
MedLine Citation:
PMID:  22621274     Owner:  NLM     Status:  Publisher    
Transfusion-Related Acute Lung Injury (TRALI) is the leading cause of transfusion-related mortality in most developed countries. Despite this fact, well-designed investigations on specific management strategies for TRALI are lacking. Indeed, current recommendations are primarily based on data extrapolated from trials of the histo-pathologically similar Acute Lung Injury and Acute Respiratory Distress Syndromes. The cornerstone of TRALI management is supportive care with oxygen supplementation and ventilatory assistance when needed. When mechanical ventilation is required, attenuating additional ventilator-induced lung injury through the avoidance of high tidal volumes and elevated airway pressures, with additional measures such as positive end-expiratory pressure to prevent low-volume shear stress injury, are recommended. The literature is not currently sufficient to support either corticosteroids or statins as effective therapies in TRALI. Conservative fluid practices are desirable, provided care is taken to avoid hypotension. Preventative strategies have shown the most promise in mitigating this transfusion-related pulmonary complication. Specifically, conservative transfusion practices and deferral of high-plasma component donors who have, or at high risk of having, anti-human leukocyte antigen and/or anti-human neutrophil antigen antibodies have meaningfully impacted the incidence of TRALI. Future considerations for patients who are at increased risk for developing TRALI may include therapies such as anti-platelet agents and alternatives to traditional blood components such as prothrombin complex concentrates (PCC). However, these potential TRALI prevention strategies are insufficiently studied, have unclear risk/benefit profiles and cannot be currently recommended.
Andrew D Goldberg; Daryl J Kor
Related Documents :
18651004 - Atrial conduction delay and its association with left atrial dimension, left atrial pre...
11348964 - The effect of cardiomyoplasty on left atrial function in experimental canine models.
525364 - Resetting of cardiac c-fiber endings in the spontaneously hypertensive rat.
2937724 - Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs.
22425704 - Evaluating home blood pressure in treated hypertensives in comparison with the referent...
15742234 - Bone chemical structure response to mechanical stress studied by high pressure raman sp...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-22
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Fellow, Critical Care Medicine, Division of Critical Care Medicine, Mayo Clinic, 200 First Street S.W. Rochester, MN 55905.;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevention of Immune-mediated Transfusion-related Acute Lung Injury; from Bloodbank to Patient.
Next Document:  Association of tobacco use and periapical pathosis - a systematic review.